![Graphic with text overlay. Text reads Using Artificial Intelligence and Machine Learning in the Development of Drug & Biological Products](https://public4.pagefreezer.com:443/content/FDA/10-05-2023T14:26/https://www.fda.gov/files/styles/medium_3/public/AI%20and%20ML%20Graphic.png?itok=ZUvGfQbt)
FDA discusses AI and machine learning for drug development
May 10 - Paper promotes learning and discussion for regulatory clarity
May 10 - Paper promotes learning and discussion for regulatory clarity
May 10 - Recent papers illustrate the importance of these new technologies
May 9 - FDA to discuss important safety information and strategies for users
May 9 - Will cover regulatory requirements and highlight current activities
May 5 - QSAR model determines extent a drug can cross the blood brain barrier
May 2 - Conversation describes benefits, challenges of this phenomenon
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.